Literature DB >> 17450509

Gedunin, a limonoid from Xylocarpus granatum, inhibits the growth of CaCo-2 colon cancer cell line in vitro.

Shaikh J Uddin1, Lutfun Nahar, Jamil A Shilpi, Mohammad Shoeb, Tomasz Borkowski, Simon Gibbons, Moira Middleton, Maureen Byres, Satyajit D Sarker.   

Abstract

Xylocarpus granatum J. König (Meliaceae), commonly known as 'dhundul', is a Bangladeshi mangrove tree, and well distributed in a number of other countries of south-east Asia, Australia and east Africa. Traditionally, X. granatum has been used as an astringent and febrifuge, and also for the treatment of fever, malaria, thrush, cholera, dysentery and diarrhoea in many countries including Bangladesh. Two limonoids, gedunin and 1alpha-hydroxy-1,2-dihydrogedunin, the latter being new, have been isolated from the bark of Xylocarpus granatum by reversed-phase preparative HPLC, and the structures were confirmed by spectroscopic means. The cytotoxic potential of gedunin has been evaluated by the Promega's CellTiter 96 non-radioactive cell proliferation assay using the CaCo-2 colon cancer cell line (IC(50) = 16.83 microM). A summary of the biological activities of gedunin reported to date is also presented. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450509     DOI: 10.1002/ptr.2159

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  24 in total

Review 1.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

2.  Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.

Authors:  Chaitanya A Patwardhan; Abdul Fauq; Laura B Peterson; Charles Miller; Brian S J Blagg; Ahmed Chadli
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

3.  Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT protein-dependent extraction of ceramides from the endoplasmic reticulum.

Authors:  Françoise Hullin-Matsuda; Nario Tomishige; Shota Sakai; Reiko Ishitsuka; Kumiko Ishii; Asami Makino; Peter Greimel; Mitsuhiro Abe; Elad L Laviad; Michel Lagarde; Hubert Vidal; Tamio Saito; Hiroyuki Osada; Kentaro Hanada; Anthony H Futerman; Toshihide Kobayashi
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

Review 4.  Antimicrobial compounds from mangrove plants: A pharmaceutical prospective.

Authors:  Jayanta Kumar Patra; Yugal Kishore Mohanta
Journal:  Chin J Integr Med       Date:  2014-01-30       Impact factor: 1.978

5.  Anticancer effects of crude extract from Melia toosendan Sieb. et Zucc on hepatocellular carcinoma in vitro and in vivo.

Authors:  Xiao-Ling Liu; Hong Wang; Ling Zhang; You-Liang Wang; Jin Wang; Peng Wang; Xiao He; Yu-Juan He
Journal:  Chin J Integr Med       Date:  2015-09-17       Impact factor: 1.978

6.  Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships.

Authors:  Gary E L Brandt; Matthew D Schmidt; Thomas E Prisinzano; Brian S J Blagg
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

Review 7.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

8.  Deoxygedunin, a natural product with potent neurotrophic activity in mice.

Authors:  Sung-Wuk Jang; Xia Liu; Chi Bun Chan; Stefan A France; Iqbal Sayeed; Wenxue Tang; Xi Lin; Ge Xiao; Raul Andero; Qiang Chang; Kerry J Ressler; Keqiang Ye
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

Review 9.  Novel small molecule activators of the Trk family of receptor tyrosine kinases.

Authors:  Obiamaka Obianyo; Keqiang Ye
Journal:  Biochim Biophys Acta       Date:  2012-09-06

Review 10.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.